Autologous Muscle-Derived Cells for Urinary Sphincter Regeneration: Where are we now?
- 22 Downloads
Purpose of Review
Stress urinary incontinence (SUI) remains a strikingly common condition faced by women with substantial economic and quality of life impact. Embarking upon treatment for incontinence often culminates with invasive surgical procedures with recognized complication profiles. Innovative directions for SUI therapeutics are on the horizon, including the utilization of adult autologous muscle-derived cells for urinary sphincter regeneration (AMDC-USR).
Current published literature presents safety and efficacy data regarding AMDC-USR injection in 80 patients at 12-month follow-up. No adverse events attributed to the cellular product were reported. Compared to lower dose groups, the higher dose groups demonstrated enhanced percentages of patients with at least 50% reduction in stress leaks and pad weight at 12-month follow-up. All dose groups had statistically significant improvement in patient-reported incontinence-specific quality of life scores at 12-month follow-up. Conclusions from the pooled analyses indicate that injection of AMDC-USR across a range of dosages appears safe. Efficacy data suggests a dose response with more patients responsive to the higher doses of AMDC-USR.
Promising technologies for utilization of autologous cellular therapies for treatment of SUI, and conceivably multiple additional indications, are approaching fruition. Multiple phase III randomized, placebo-controlled studies for AMDC-USR are ongoing to bring this regenerative option forth for the millions of patients who may ultimately benefit.
KeywordsStress urinary incontinence Regenerative therapy Autologous muscle-derived cells
Compliance with Ethical Standards
Conflict of Interest
Dr. Kaufman serves as the Global Principal Investigator for Cook Myosite.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major Importance
- 11.Hwang K, Lewis S, Lamb DJ. Stem cell research: implications for urology. AUA Update Series. 2010;29(8):77–84.Google Scholar
- 14.Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N, et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn. 2000;19(3):279–87.CrossRefGoogle Scholar
- 17.Kwon D, Kim Y, Pruchnic R, Jankowski R, Usiene I, de Miguel F, et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology. 2006;68(2):449–54.CrossRefGoogle Scholar
- 22.Lee JY, Cannon TW, Pruchnic R, Fraser MO, Huard J, Chancellor MB. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003;14(1):31–37; discussion 7.Google Scholar
- 25.• Carr LK, Robert M, Kultgen PL, Herschorn S, Birch C, Murphy M, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601. Pooled data from phase I/II studies on safety and efficacy of AMDS-USR. CrossRefGoogle Scholar
- 27.Carr L, Tu LM, Robert M, Quinlan D, Carlson K, Herschorn S, Dmochowski R, Peters K, Kaufman M, Jankowski R, Chancellor M. Autologous muscle derived cells for urinary sphincter repair for recurrent or persistent stress urinary incontinence after continence surgery. AUA Annual Meeting; 2017; Boston.Google Scholar
- 28.Pruchnic R, Jankowski R and Kaufman MR. Lessons learned from a multicenter, randomized, double-blind, placebo controlled study of autologous muscle derived cells for urinary sphincter repair. International Continence Society Annual Meeting. 2017; Florence, Italy.Google Scholar
- 29.Quinlan D, Carr L, Tu LM, Robert M, Carlson K, Herschorn S, Dmochowski R, Peters K, Kaufman M, Jankowski R and Chancellor M. Autologous muscle derived cells for urinary sphincter repair for recurrent or persistent stress urinary incontinence after continence surgery. IUGA. 2017; Vancouver, Canada.Google Scholar